Lekhmici Arrar1,
Hayat Trabsa1 ,
Abderrahmane Baghiani1,
Naouel Boussoualim1,
Imane Krache1,
Seddik Khennouf2,
Noureddine Charef1,
1Laboratory of Applied Biochemistry;
2Laboratory of Phytotherapy Applied to Chronic Diseases, Faculty of Nature and Life Sciences, Univ. Setif, Setif 19000, Algeria.
For correspondence:- Hayat Trabsa
Email: hayat.trab@yahoo.fr Tel:+213560954133
Received: 28 October 2014
Revised: 12 January 2015
Published: 28 February 2015
Citation:
Arrar L, Trabsa H, Baghiani A, Boussoualim N, Krache I, Khennouf S, et al.
Kinetics of inhibition of xanthine oxidase by Lycium arabicum and its protective effect against oxonate-induced hyperuricemia and renal dysfunction in mice. Trop J Pharm Res 2015; 14(2):249-256
doi:
10.4314/tjpr.v14i2.9
© 2015 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..
Abstract
Purpose:To evaluate the in-vitro inhibition of xanthine oxidase (purified from bovine milk) by extracts of Lycium arabicum, as well as it is in vivo hypouricemic and renal protective effects.
Methods:Four extracts of Lycium arabicum, methanol (CrE), chloroform (ChE), ethyl acetate (EaE) and aqueous (AqE) extracts, were screened for their total phenolics and potential inhibitory effects on purified bovine milk xanthine oxidase (XO) activity by measuring the formation of uric acid or superoxide radical. The mode of inhibition was investigated and compared with the standard drugs, allopurinol, quercitin and catechin. To evaluate their hypouricemic effect, the extracts were administered to potassium oxonate-induced hyperuricemic mice at a dose of 50 mg/kg body weight.
Results:The results showed that EaE had the highest content of phenolic compounds and was the most potent inhibitor of uric acid formation (IC50 = 0.017 ± 0.001 mg/mL) and formation of superoxide (IC50 = 0.035 ± 0.001 mg/ml). Lineweaver-Burk analysis showed that CrE and EaE inhibited XO competitively, whereas the inhibitory activities exerted by ChE and AqE were of a mixed type. Intraperetoneal injection of L. arabicum extracts (50 mg/kg) elicited hypouricemic actions in hyperuricemic mice. Hyperuricemic mice presented a serum uric acid concentration of 4.71 ± 0.29 mg/L but this was reduced to 1.78 ± 0.11 mg/L by EaE, which was the most potent hyporuricemic extract.
Conclusion:L. arabicum fractions have a strong inhibitory effect on xanthine oxidase and and also have a significantly lowering effect on serum and liver creatinine and urea levels in hyperuricemic mice.
Keywords: Lycium arabicum, Uric acid, Creatinine, Superoxide, Phenolic compounds, Flavonoids, Hyperuricemia